Concord Medical Services Holdings (CCM) Cost of Revenue (2009 - 2025)

Concord Medical Services Holdings has reported Cost of Revenue for 17 years, with the latest figure at $2.9 million in Q2 2025.

• For the quarter ending Q2 2025, Cost of Revenue fell 14.69% year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2025 stood at $13.9 million (up 6.21% YoY), and the FY2025 full-year result was $62.2 million, down 2.03% from the prior year.
• Cost of Revenue for Q2 2025 stood at $2.9 million, down from $3.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $3.9 million in Q2 2022, with the low at $2.1 million in Q2 2021.
• Historically, Cost of Revenue has averaged $3.2 million across 5 years, with a median of $3.4 million in 2024.
• Annual changes were most pronounced in 2021 — Cost of Revenue tumbled 32.33% — and 2022, when it surged 86.39%.
• Concord Medical Services Holdings' Cost of Revenue stood at $2.1 million in 2021, then surged by 86.39% to $3.9 million in 2022, then declined by 7.83% to $3.6 million in 2023, then decreased by 5.45% to $3.4 million in 2024, then decreased by 14.69% to $2.9 million in 2025.
• The last three Cost of Revenue figures came in at $2.9 million (Q2 2025), $3.4 million (Q2 2024), and $3.6 million (Q2 2023), per Business Quant data.